Endovascular Treatment Devices: EVAR and TEVAR Emphasis

Report Code: HLC203A

Publish Date: Sep 2018

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for endovascular treatment devices reached $2.0 billion in 2017 and should reach nearly $2.8 billion by 2022, at a compound annual growth rate (CAGR) of 7.3% from 2017 to 2022.

Report Includes 

  • 20 data tables and 14 additional tables
  • A global overview of the endovascular treatment market with an emphasis on Endovascular Aortic Repair (EVAR) and Thoracic Endovascular Aortic/aneurysm Repair (TEVAR)
  • Analyses of global market trends with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of the endovascular treatment market's regulatory structure, pricing and reimbursement, and marketed and pipelined products
  • Information on endovascular surgery techniques, procedural risks and follow-up treatment, and the clinical need for endovascular procedures
  • Company profiles of major players in the industry, including Boston Scientific Corp., Cardinal Health, Cook Group Inc., Getinge AB and Terumo Corp.

Report Scope

Endovascular treatment includes procedure types such as EVAR and TEVAR. Aneurysm types include infrarenal, juxtarenal and thoracic. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for endovascular treatment for aneurysms. The format of this study includes the following: 

  • Detailed description, including demographics and cost burden, of aortic diseases (abdominal aortic aneurysms and thoracic aortic aneurysms) and aneurysm types (e.g., infrarenal, juxtarenal and thoracic).
  • Detailed description and analysis of endovascular treatment devices including EVAR and TEVAR.
  • Market characterization, including unmet need, market size, and segmentation (by region and treatment).
  • Market drivers and restraints.
  • Detailed market projections through 2022.
  • Competition and market shares.
  • Key marketed and pipeline (R&D) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure.
  • Pricing and reimbursement.
  • Observations and conclusions regarding the future of endovascular treatment.
  • Profiles of market participants and associations.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Dr. Ritu Thakur is an independent consultant based in New Delhi, India with 10+ years of experience in consulting, business/market research, business & report writing, analytics, content development & management and translation. She has prior work experience with Panasonic (Healthcare Division), GlobalData (U.K.-based market research firm) and several other development stage/early stage companies including Biovo, Diabesity, Medibrane, ScaleThings, EndoGI, Ramot Biomedical Eng and NeverWet. In her previous assignments, she has delivered hundreds of small to large scale custom projects on pharmaceutical, medical and biotechnology subjects. She has developed reports for BCC Research for more than four years and has worked as an author for healthcare and other related industries such as pharmaceuticals, biotechnology and medical devices.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Endovascular Treatment Devices: EVAR and TEVAR Emphasis124Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Aortic Aneurysm17Free
Chapter- 4: Abdominal Aortic Aneurysms26Free
Chapter- 5: Thoracic Aortic Aneurysms16Free
Chapter- 6: Market Size and Growth Analysis11Free
Chapter- 7: Competitive Landscape in Endovascular Treatment Market2Free
Chapter- 8: Market Strategies in the Endovascular Treatment Market5Free
Chapter- 9: Regulatory Structure: Medical Devices7Free
Chapter- 10: Pricing and Reimbursement: Medical Devices4Free
Chapter- 11: Conclusions-Outlook for Endovascular Treatment Devices5Free
Chapter- 12: Company Profiles15Free
Chapter- 13: Appendix A: Acronyms2Free
Chapter- 14: Appendix B: Professional Organizations4Free

Related Reports

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

mRNA: Therapeutics and Global Markets

Published - Jan 2024 | Publisher - BCC Publishing | Code - BIO212B

The global market for mRNA therapeutics is expected to decline from $33 billion in 2023 to $21 billion by the end of 2028, at a compound annual growth rate (CAGR) of -8.6% during the forecast period of 2023-2028.

The Market for Minimally Invasive Medical Devices

Published - Aug 2023 | Publisher - Kottapenta Sai Ratna Bramara Kalyani | Code - HLC051J

The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.

Recent Reports

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - HLC071E

The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.

Top Trending Reports

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Endovascular Treatment Devices: EVAR and TEVAR Emphasis
Customize Report